Zhen-Yu Ding
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs (NCT06329908) | Zhen-Yu Ding | 2023-09-27 |
| A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC） (NCT05025631) | Zhen-Yu Ding | 2020-11-06 |
Track Zhen-Yu Ding automatically
Every clearance here is in the API, with alerts when new ones post.